Emily Gottschalk's most recent trade in Anixa Biosciences Inc was a trade of 25,000 Employee Stock Option done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 25,000 | 25,000 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Purchase of securities on an exchange or from another person at price $ 3.96 per share. | 15 Jul 2021 | 20,065 | 45,665 (0%) | 0% | 4.0 | 79,457 | Common Stock |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 30,000 | 30,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Purchase of securities on an exchange or from another person at price $ 4.49 per share. | 23 Apr 2021 | 10,000 | 25,600 (0%) | 0% | 4.5 | 44,900 | Common Stock |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Purchase of securities on an exchange or from another person at price $ 4.88 per share. | 25 Mar 2021 | 15,600 | 15,600 (0%) | 0% | 4.9 | 76,128 | Common Stock |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2020 | 30,000 | 30,000 | - | - | Employee Stock Option (Right to Buy) |